Emergency Classification According to Fingertip Circulation

March 12, 2024 updated by: Cumhur Murat TULAY, Manisa Celal Bayar University

DYSPNEA: PERFUSION INDEX and TRIAGE STATUS (the Name of the Project)

Dyspnea is one of the most common reasons for admission to the emergency department[1]. Oxygen saturation has great importance in determining the triage status of patients admitted to the hospital with dyspnea and planning the emergency treatment [2].

Peripheral perfusion index (PI), which shows tissue oxygenation is a noninvasive way of demonstrating tissue perfusion in critically ill patients. Studies have shown that PI is an accurate, fast and reliable pulse oximetry-based indicator of tissue perfusion [3-5]. PI shows the perfusion status of the tissue in the applied area for an instant and a certain time interval. The PI value ranges from 0.02% (very weak) to 20% (strong) [6].

Triage scales are used to distinguish emergency and non-emergency patients. The emergency triage system is used to quickly determine the care priorities of patients during admission to the emergency department[7,8].

It is important to make the triage classification for dyspnea in emergency services quickly and accurately to start the treatment protocols as early as. In this study, the investigators aimed to determine the relationship between perfusion index and the emergency triage classification in patients admitted to the emergency department with dyspnea.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Purpose: To determine the effect of PI measurement on the emergency triage classification in patients with dyspnea.

Methods: Adult patients who presented with dyspnea and whose perfusion index values were measured with Masimo Radical-7 device at the time of admission, at the first hour and the second hour of admission were included in the study. The PI and oxygen saturation measured by finger probes were compared and the superiority of their effects on the emergency triage classification was compared.

Study Type

Interventional

Enrollment (Actual)

1490

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Manisa, Turkey, 45030
        • Manisa Celal Bayar University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients over the age of 18 who presented with dyspnea
  • whose perfusion index values were measured at the time of first admission (arrival time), at the first hour and the second hour of admission were included in the study

Exclusion Criteria:

  • Patients who applied due to the mechanism of trauma,
  • patients with known vascular disease (Buerger's disease, peripheral artery disease, etc.), -patients with COVID-19 PCR positivity
  • whose perfusion index measurement could not be completed due to hospitalization or discharge were excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Triage status red
the relationship between the perfusion index and the emergency triage classification in patients admitted to the emergency department with dyspnea.
perfusion index measuring device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perfusion index use for triage status
Time Frame: perfusion index measurement at the time of first admission to hospital
for determination of triage status of patients with dyspnea with using perfusion index
perfusion index measurement at the time of first admission to hospital
Perfusion index use for triage status
Time Frame: perfusion index measurement at the time of the first hour after admission to hospital
for determination of triage status of patients with dyspnea with using perfusion index
perfusion index measurement at the time of the first hour after admission to hospital
Perfusion index use for triage status
Time Frame: perfusion index measurement at the time of the second hour after admission to hospital
for determination of triage status of patients with dyspnea with using perfusion index
perfusion index measurement at the time of the second hour after admission to hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cumhur M TULAY, Ass.Prof., Ass.Prof.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

January 1, 2021

Study Completion (Actual)

January 1, 2021

Study Registration Dates

First Submitted

January 31, 2023

First Submitted That Met QC Criteria

February 21, 2023

First Posted (Actual)

February 23, 2023

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 10.10.2018 and 20.478.486
  • Manisa Celal Bayar University (Other Identifier: 2018-213)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The result will be explained in the manuscript when published.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyspnea

Clinical Trials on Masimo Radical-7

Subscribe